Skip to content

Author

Yu-Lu Yang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Proteomics in Antitumor Drug Target Discovery, Toxicity, Resistance, and Precision Oncology

Proteomics strategies are discussed, which enable the profiling of adverse drug reactions, the dissection of resistance mechanisms, and the advancement of precision oncology in antitumor drug development and precision oncology.

Qiang-Feng Zhong, Xiu-Li Wu, E. Wiechec et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.